Analyst Stock Ratings Upgrades

Analyst upgrades are typically bullish for a stock. When there is a stock upgrade, the analysts who rate the stock feel better about the company's future and typically either recommend someone holds or buys the stock. Updated 07/07/2024

Buy NowGet Alert
07/03/2024ANTXBuy Now
AN2 Therapeutics
$2.58—Leerink Partners
Joseph Schwartz53%
—UpgradeMarket Perform → OutperformGet Alert
07/03/2024DOYUBuy Now
DouYu Intl Hldgs
$17.61-14.82%HSBC
Ritchie Sun41%
 → $15UpgradeReduce → HoldGet Alert
07/03/2024DEOBuy Now
Diageo
$128.78—Citigroup
Simon Hales58%
—UpgradeNeutral → BuyGet Alert
07/03/2024MATRBuy Now
Mattr
——RBC Capital
Arthur Nagorny53%
$18 → $20UpgradeSector Perform → OutperformGet Alert
07/03/2024PAMBuy Now
Pampa Energia
$46.3025.27%Citigroup
Andres Cardona41%
$51 → $58UpgradeNeutral → BuyGet Alert
07/03/2024PRBuy Now
Permian Resources
$16.2029.63%BMO Capital
Phillip Jungwirth73%
$21 → $21UpgradeMarket Perform → OutperformGet Alert
07/03/2024FFWMBuy Now
First Foundation
$5.1574.76%DA Davidson
Gary Tenner50%
$8 → $9UpgradeNeutral → BuyGet Alert
07/02/2024CMABuy Now
Comerica
$50.0519.88%Raymond James
Michael Rose66%
 → $60UpgradeMarket Perform → OutperformGet Alert
07/02/2024BACBuy Now
Bank of America
$41.0117.04%Seaport Global
Jim Mitchell66%
 → $48UpgradeNeutral → BuyGet Alert
07/02/2024PFGBuy Now
Principal Finl Gr
$78.7721.87%JP Morgan
Jimmy Bhullar65%
$88 → $96UpgradeUnderweight → NeutralGet Alert
07/02/2024PYPLBuy Now
PayPal Holdings
$59.3519.63%Susquehanna
Anthony Butler31%
$71 → $71UpgradeNeutral → PositiveGet Alert
07/02/2024TEAMBuy Now
Atlassian
$182.1123.55%Piper Sandler
Rob Owens86%
$200 → $225UpgradeNeutral → OverweightGet Alert
07/01/2024ICEBuy Now
Intercontinental Exchange
$141.1718.3%Goldman Sachs
Alexander Blostein75%
 → $167UpgradeNeutral → BuyGet Alert
07/01/2024ADNTBuy Now
Adient
$23.968.51%Exane BNP Paribas
James Picariello75%
 → $26UpgradeUnderperform → NeutralGet Alert
07/01/2024MGABuy Now
Magna International
$42.56—Exane BNP Paribas
James Picariello75%
—UpgradeNeutral → OutperformGet Alert
07/01/2024AGROBuy Now
Adecoagro
$9.7817.59%JP Morgan
Lucas Ferreira44%
$10.5 → $11.5UpgradeUnderweight → NeutralGet Alert
07/01/2024TFXBuy Now
Teleflex
$211.7315.71%Piper Sandler
Matt O'Brien46%
$205 → $245UpgradeNeutral → OverweightGet Alert
07/01/2024RTOBuy Now
Rentokil Initial
$30.72—UBS——UpgradeSell → NeutralGet Alert
07/01/2024BIRKBuy Now
Birkenstock Holding
$56.7649.75%UBS
Jay Sole69%
$52 → $85UpgradeNeutral → BuyGet Alert
07/01/2024COLDBuy Now
Americold Realty Trust
$25.9919.28%Wolfe Research
Andrew Rosivach48%
 → $31UpgradePeer Perform → OutperformGet Alert
06/28/2024DLRBuy Now
Digital Realty Trust
$153.6613.89%JP Morgan
Richard Choe47%
$150 → $175UpgradeNeutral → OverweightGet Alert
06/28/2024CINFBuy Now
Cincinnati Financial
$116.6315.75%Citigroup
Michael Ward75%
$126 → $135UpgradeNeutral → BuyGet Alert
06/28/2024IPBuy Now
International Paper
$43.1520.51%Seaport Global
Mark Weintraub78%
 → $52UpgradeNeutral → BuyGet Alert
06/28/2024GHBuy Now
Guardant Health
$27.6030.42%Guggenheim
Subbu Nambi46%
 → $36UpgradeNeutral → BuyGet Alert
06/28/2024SAPBuy Now
SAP
$202.7916.87%BMO Capital
Keith Bachman81%
$218 → $237UpgradeMarket Perform → OutperformGet Alert
06/28/2024EQRBuy Now
Equity Residential
$67.9917.66%Piper Sandler
Alexander Goldfarb59%
$70 → $80UpgradeNeutral → OverweightGet Alert

Recent Analyst Stock Rating Upgrade News

Baird Maintains Outperform on Albemarle, Lowers Price Target to $127
Baird analyst Ben Kallo maintains Albemarle (NYSE:ALB) with a Outperform and lowers the price target from $170 to $127.
Baird Maintains Outperform on McKesson, Raises Price Target to $694
Baird analyst Eric Coldwell maintains McKesson (NYSE:MCK) with a Outperform and raises the price target from $679 to $694.
Keybanc Maintains Overweight on Qualcomm, Raises Price Target to $225
Keybanc analyst John Vinh maintains Qualcomm (NASDAQ:QCOM) with a Overweight and raises the price target from $205 to $225.
Baird Maintains Outperform on Cencora, Raises Price Target to $285
Baird analyst David Rodgers maintains Cencora (NYSE:COR) with a Outperform and raises the price target from $280 to $285.
Baird Maintains Outperform on Cardinal Health, Raises Price Target to $130
Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $129 to $130.
TD Cowen Initiates Coverage On Exscientia with Buy Rating
TD Cowen analyst Brendan Smith initiates coverage on Exscientia (NASDAQ:EXAI) with a Buy rating.
TD Cowen Initiates Coverage On Tempus AI with Buy Rating, Announces Price Target of $50
TD Cowen analyst Dan Brennan initiates coverage on Tempus AI (NASDAQ:TEM) with a Buy rating and announces Price Target of $50.
BTIG Initiates Coverage On Veeva Systems with Buy Rating, Announces Price Target of $240
BTIG analyst David Larsen initiates coverage on Veeva Systems (NYSE:VEEV) with a Buy rating and announces Price Target of $240.
HC Wainwright & Co. Downgrades HilleVax to Neutral
HC Wainwright & Co. analyst Matthew Caufield downgrades HilleVax (NASDAQ:HLVX) from Buy to Neutral.
HC Wainwright & Co. Reiterates Buy on Immix Biopharma, Maintains $7 Price Target
HC Wainwright & Co. analyst Robert Burns reiterates Immix Biopharma (NASDAQ:IMMX) with a Buy and maintains $7 price target.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free